MKS Inc. (MKSI) Guidance & Earnings Results

On 2026-08-05 MKS Inc. raised guidance: "Q3 2026 revenue $1,350M ±$40M; Non-GAAP EPS $3.58 ±$0.31; Adj. EBITDA $395M ±$28M; Gross margin 47.0%…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MKSIMKS Inc.Follow MKSI — free

Scientific & Technical Instruments · Technology

—

Price chart with a free account

Market cap: 13.3B
P/E TTM: 31.3
Dividend yield: 0.5%
52-week: —
Next earnings: 4 Nov, in 11 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
5 Aug 26	Raised	Q3 2026 revenue $1,350M ±$40M; Non-GAAP EPS $3.58 ±$0.31; Adj. EBITDA $395M ±$28M; Gross margin 47.0% ±1.0%
6 May 26	Raised	Q2 revenue $1,200M, adj EBITDA $328M, non-GAAP EPS $2.90
17 Feb 26	Raised	Q1 FY2026 revenue guidance midpoint $1,040M vs Q4 FY2025 actual $1,033M; Adj EBITDA guidance $251M vs Q4 actual $249M.
21 Jan 26	Raised	Revenue guidance raised by $40M to ~$1.03B; GAAP net income ~$106M; Adjusted EBITDA ~$248M
5 Nov 25	Raised	Q4 2025 revenue guidance $990M ± $40M; Non-GAAP EPS $2.27 ± $0.34
6 Aug 25	Raised	Q3 FY2025 revenue $960M ±$40M; GAAP net income $67M ±$21M; Non-GAAP net earnings $121M ±$19M; GAAP EPS $0.99 ±$0.31; Non-GAAP EPS $1.80 ±$0.29; Adjusted EBITDA $232M ±$24M; Gross margin 46.5% ±1.0%

MKS Inc. — questions

What guidance did MKS Inc. give?: On 2026-08-05: "Q3 2026 revenue $1,350M ±$40M; Non-GAAP EPS $3.58 ±$0.31; Adj. EBITDA $395M ±$28M; Gross margin 47.0% ±1.0%"
When does MKS Inc. report earnings?: MKS Inc.'s next earnings report is expected on 2026-11-04.

Every figure on this page comes from MKS Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.